Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation

(2017) Oscar M. Pello et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

(2016) Swati Naik et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation

(2016) Rita Creidy et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection

(2016) Chongsheng Qian et al.   JOURNAL OF IMMUNOTHERAPY

Impact of HLA in cord blood transplantation outcomes

(2016) A. Ruggeri et al.   HLA

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

(2015) J. Feucht et al.   BLOOD

Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies

(2015) Giovanna Lucchini et al.   CYTOTHERAPY

Current issues in chronic graft-versus-host disease

(2014) G. Socie et al.   BLOOD

A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent

(2014) J J Scarisbrick et al.   BONE MARROW TRANSPLANTATION

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease

(2014) Mark A. Vickers et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antiviral T-cell therapy

(2014) Ann M. Leen et al.   IMMUNOLOGICAL REVIEWS

Recommandations de la SFGM-TC concernant l’injection prophylactique, préemptive et curative des lymphocytes du donneur (DLI) après allogreffe de cellules souches hématopoïétiques

(2014) T. Guillaume et al.   PATHOLOGIE BIOLOGIE

Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation

(2013) Ying-Jun Chang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

(2013) A. M. Leen et al.   BLOOD

Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

(2013) Waseem Qasim et al.   BRITISH JOURNAL OF HAEMATOLOGY

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy

(2013) Yingying Wang et al.   CYTOTHERAPY

Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation

(2013) Matteo Di Nardo et al.   PEDIATRIC BLOOD & CANCER

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

(2012) Vanya Icheva et al.   JOURNAL OF CLINICAL ONCOLOGY

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)

(2012) S. Matthes-Martin et al.   Transplant Infectious Disease

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

(2011) Diana F. Florescu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation

(2011) Maud D'Aveni et al.   TRANSPLANT IMMUNOLOGY

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

(2010) T. Feuchtinger et al.   BLOOD

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001

(2010) Kris Paolino et al.   JOURNAL OF CLINICAL VIROLOGY

Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

(2010) Lamia Aïssi-Rothé et al.   JOURNAL OF IMMUNOTHERAPY

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

(2007) Stephen Mackinnon et al.   BLOOD CELLS MOLECULES AND DISEASES